Remus Pharmaceuticals Ltd Share Price

Pharmaceuticals

NSE: REMUS Small Cap ISIN: INE0O5T01011

As on 13 June 2026 at 01:08 IST

₹684

+ 1.20

(0.18%)

Sell Buy

Over 1 Month

-9.50%

Over 6 Months

-5.94%

Over 1 Year

-29.15%

Over 3 Years

111.07%

Remus Pharmaceuticals Ltd Summary

Close ₹682.80

Open ₹679

High ₹684.95

Low ₹679

Volume 1,700

Net Turnover (in Cr) ₹0.11

52Wk High -

52Wk Low -

52Wk High / Low

Remus Pharmaceuticals Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹804.61

EPS (TTM) 20.97

Book Value (BV) 276.40

Div. Yield 0.07 %

P/E (TTM) 32.56

Price/Book Value 2.47

Delivery % 88.24 %

Face Value 10

Key Ratios

PE Ratio 66.26

PB Ratio 5.44

EV to Sales 16.66

PEG Ratio -0.95

ROA 8.05

ROE 10.06

Debt-Equity 0.02

Net Profit Margin 25.14

Operating Profit Margin 36.50

Remus Pharmaceuticals Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024
Total Revenue	625.34	215.77
Total Expenses	578	185.60
Profit Before Tax	47.34	30.17
Profit After Tax	38.42	24.28
Operating Profit After Depreciation	48.80	30.67

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024
Fixed Assets	15.82	13.79
Total Non Current Assets	211.27	120.78
Total Current Assets	221.37	212.33
Total Assets	432.64	333.11
Total Shareholder's Fund	255.86	157.69

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024
Net Cash From Operating Activities	6.99	1.35
Net Cash Used In Investing Activities	-10.55	-25.31
Net Cash Used In Financing Activities	6.07	27.67

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	82.07	66.75	46.60	25.44	19.22
Total Expenses	55.43	44.40	35.19	20.82	17.82
Profit Before Tax	26.64	22.35	11.41	4.61	1.41
Profit After Tax	19.90	16.62	8.50	3.43	1.06
Operating Profit After Depreciation	27.02	22.69	11.65	4.70	1.44

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	7.07	5.06	2.54	0.31	0.39
Total Non Current Assets	226.40	134.61	23.32	8.17	3.52
Total Current Assets	53.91	48.88	11.34	7.69	7.50
Total Assets	280.31	183.49	34.66	15.86	11.02
Total Shareholder's Fund	242.22	153.55	19.14	6.58	3.14

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	15.59	6.31	5.31	5.04	-0.12
Net Cash Used In Investing Activities	-12.42	-47.24	-15.19	-4.55	-0.13
Net Cash Used In Financing Activities	-1.42	41.63	11.77	-0.17	-0.11

No data available

Remus Pharmaceuticals Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 679.55

S2 676.30

S3 673.60

Pivot 682.25

R1 685.50

R2 688.20

R3 691.45

Moving Average

20 SMA 751.88

50 SMA 701.45

100 SMA 682.72

200 SMA 722.18

Remus Pharmaceuticals Ltd Corporate Actions

Remus Pharmaceuticals Ltd

₹0.5/Share

Announcement Date 14 Nov 2025

Record Date 14 Nov 2025

Div Yield 5%

Remus Pharmaceuticals Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Remus Pharmaceuticals Ltd Top Mutal Funds Invested

No data available

Remus Pharmaceuticals Ltd News

Board of Remus Pharmaceuticals recommends final dividend

Of Rs 0.5 per share

21 May 2026, 12:02 pm

Remus Pharmaceuticals to announce Quarterly Result

On 20 May 2026

14 May 2026, 03:05 pm

Board of Remus Pharmaceuticals recommends First Interim Dividend

Of Rs.0.50 per share

10 Nov 2025, 03:41 pm

Remus Pharmaceuticals to table results

On 10 November 2025

03 Nov 2025, 05:05 pm

Remus Pharmaceuticals to convene AGM

On 25 September 2025

09 Sep 2025, 09:58 am

Remus Pharmaceuticals Ltd Stock Analysis

Annual revenue for Remus Pharmaceuticals Ltd increased by 22.95% to ₹82.07 crore in FY 2025 from ₹66.75 crore in FY 2024.
Annual Net Profit for Remus Pharmaceuticals Ltd increased by 19.74% to ₹19.90 crore in FY 2025 from ₹16.62 crore in FY 2024.
Promoter Shareholding in Remus Pharmaceuticals Ltd increased by 0.07% in the most recent quarter, from 70.91% in September 2025 to 70.95% in March 2026.
Remus Pharmaceuticals Ltd delivered a 1-year return of -29.15% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Remus Pharmaceuticals Ltd share price moved up by 0.18% from its previous close of INR ₹682.80. The latest Remus Pharmaceuticals Ltd share price is INR ₹684.
Remus Pharmaceuticals Ltd share price today has been at a low of 684 and a high of 685. Over the past 52 weeks, the Remus Pharmaceuticals Ltd share price has seen a low of 580 and a high of 1,021.80.